Strictly Private and Confidential
Indian Consumer Goods: Resilience continues Indian Consumer Goods: Resilience continues
Abneesh Roy Harsh Mehta
+91-22-6620 3141 +91-22-4063 5543
[email protected] [email protected]
February 2012
Key trends in Q3FY12
Volume spurs : Volume for 12 out of 13 companies in line or better than expectations; positive surprises: Asian Paints, Marico and Dabur. This is in sharp contrast to many media and street Q3FY12 forecasts of a sharp slowdown in rural demand and inventory pile up.
Ad spend remain soft, but some pick up: Six companies (out of 13) cut it in terms of % of sales (v/s. 10 out of 13 in Q2FY12). Four trimmed ad spends on absolute basis.
Strain on gross margin persist: Gross margins of 12 companies (out of 21) dipped i ifi tl ( t GCPL M i N tl E i B it i A T h d i tt significantly (except GCPL, Marico, Nestle, Emami, Britannia, Agro Tech and cigarette
companies).
EBIDTA margin dips: EBITDA margin of 12 (out of 21) companies declined, though much lower than gross margin (Dabur USL Zydus Wellness Pidilite and Bajaj Corp saw a high decline)than gross margin (Dabur, USL, Zydus Wellness, Pidilite and Bajaj Corp saw a high decline).
Pricing power rises: Majority took calibrated price hikes. Quality of sales growth was better with balanced blend of price and volume growth.
N l h i k C i i i i h i i d d l h New launches pick up pace: Companies are persisting with innovations and product launches across segments, and pace seen improving from the previous quarter.
International businesses continue to bloom: In most cases, businesses reported healthy growth despite global economic pressures Emami disappointed in Africa Dabur in Turkeygrowth despite global economic pressures. Emami disappointed in Africa, Dabur in Turkey.
Q3FY12 results | Hits: GCPL, Marico, Colgate, Asian Paints, Dabur. Flops: USL.
Top picks: Dabur, Marico, GCPL and ITC.
2
Outlook for coming quarters: Upbeat
Volume: To remain healthy as penetration levels and per capita usage will remain attractive for years to come. Both rural and urban India to drive demand.
Ad spend: To see a slow revival.
Gross margin: Gross margin pressure likely peaked out. Coming quarters likely to see expansion in gross margins, part of which will be ploughed back into ad spends.
India growing much faster than world average: In Dec quarter Indian volume growth India growing much faster than world average: In Dec quarter, Indian volume growth continues to be much faster than the rest of the world, justifying premium multiples.
• Colgate India reported ~15% YoY volume growth v/s parent company’s 4.0%.
d 9 % l h ’ 0 %• HUL reported 9.1% YoY volume growth against parent company’s 0.1%.
• Coca-Cola India reported a healthy 20% YoY volume growth v/s 3% for parent company.
Packaging law: The new packaging legislation could impact categories like biscuits, detergents, Packaging law: The new packaging legislation could impact categories like biscuits, detergents, tea, coffee and soaps, which in turn could affect affordability and thereby overall sales.
Budget: Tax-free slabs are expected to be raised, which will aid consumption.
3
Some unanswered questions……
Is it trend reversal of slowdown in ad spends: Some consumer companies like Dabur, Marico, GSK sharply stepped up ad spends in Dec quarter.quarter.
Laggards in margins like soaps & detergents and biscuits posted sharp recovery in margins. Is it sustainable?
Marked increase in action in toothpaste segment. Is P&G finally entering toothpaste in India?
Are margins in personal care set for a structural Are margins in personal care set for a structural downtrend?
Has India stepped up usage of hair oils as seen in strong volume growth by all hair oil companies?g g y p
4
Risks
Currency: Further MTM impact will depend on how the INR moves from INR53 (Dec end).
Hike in excise tax, reduction in fiscal benefits.
Sl d i l th d t l f d i fl ti d t b k i t dSlowdown in rural growth due to low food inflation and cut back in govt. spends.
Slowdown in discretionary items in urban areas.
Increase in ad spends, entry of new players.p , y p y
Difficulty in price hikes in lower SKUs, new packaging norms.
5
Valuation snapshot and top picks
Company Market Mcap Div yield(%)
CAGR(%)
Price (INR) (INR bn) FY11 FY12E FY13E FY11 FY12E FY13E FY11 FY12E FY13E FY11E FY12E FY13E FY13E FY11‐13E
FMCG
ROE (%)P/E( x) EV/EBITDA(x)Diluted EPS (INR)
Asian Paints 3,027 290 87.9 96.1 110.4 34.4 31.5 27.4 21.5 19.7 16.8 43.3 38.5 37.2 1.7 12.0
Colgate 1,004 137 29.6 32.2 37.8 33.9 31.2 26.6 25.1 22.7 18.8 113.4 113.9 111.7 2.7 13.0
Dabur 103 180 3.3 3.6 4.3 31.8 28.9 23.8 24.0 20.5 16.8 51.2 42.3 40.3 1.5 15.6
Emami 380 58 15.1 17.2 20.1 25.2 22.2 18.9 22.7 20.0 15.9 34.8 36.3 39.0 1.9 15.3
GlaxoSmithKline Co 2,616 110 71.3 84.5 106.9 36.7 31.0 24.5 23.0 19.4 15.0 32.8 34.6 36.2 1.6 22.5
Godrej Consumer 435 141 14.9 16.4 20.5 29.2 26.5 21.3 24.8 20.0 16.3 35.9 27.6 28.4 1.6 17.2
Hindustan Unilever 392 847 9.8 12.0 14.0 39.9 32.6 28.0 34.7 26.8 22.8 79.8 83.6 77.2 2.2 19.4
ITC 203 1580 6.6 7.9 9.0 30.6 25.6 22.4 19.8 17.3 15.1 33.2 35.9 37.2 2.7 16.8
Marico 163 100 4.7 5.2 6.5 34.9 31.3 25.1 25.5 21.2 16.9 30.3 30.5 29.6 0.6 17.9
Nestle* 4,412 425 88.7 106.2 129.9 49.7 41.5 34.0 33.7 27.1 21.7 119.1 101.5 92.6 1.8 21.0
United Spirits 676 88 35.1 30.6 38.6 19.2 22.1 17.5 12.2 11.7 10.3 11.6 9.0 10.6 1.7 4.8p
United Breweries# 461 121 6.4 7.1 11.2 72.0 64.9 41.3 30.4 24.4 17.3 15.0 15.6 18.1 0.2 32.0
Pidilite# 145 77 6.4 7.3 9.7 22.7 19.8 15.0 16.7 15.3 12.5 31.2 28.4 28.1 1.8 23.1
Britannia# 519 63 10.4 16.0 20.4 49.8 32.4 25.4 30.6 20.1 16.0 40.5 43.9 52.6 2.0 40.1
FMCG ‐ Mean 36.4x 31.5x 25.1x 24.6x 20.6x 17.0x 53.2 50.3 49.1 1.8 19.3
FMCG ‐ Mean (market cap wtd average) 35.0x 29.8x 25.4x 25.2x 21.1x 17.8x 56.3 55.3 53.3 2.2 17.2
FMCG ‐ Mean (ex‐Nestle) 31.6x 28.3x 23.5x 23.3x 19.9x 16.5x 46.6 45.2 44.7 1.8 16.0
Prices on 14‐Feb‐12 * CY numbers
6Based on our analysis, our top picks currently are Marico, ITC, Dabur and GCPL .
Source: Company, Edelweiss research
Prices on 14 Feb 12 CY numbers
# Bloomberg estimates
A detailed analysis of trends
Trend 1: Volume spur on
Consumer pack continues to surprise positively in terms of volume growth despite several price hikes with 12 out Consumer pack continues to surprise positively in terms of volume growth despite several price hikes, with 12 out of 13 companies posting volume growth in line/better than expectations.
Asian Paints surprised with ~10% volume growth (on high base) despite a slowdown in discretionary spend.
Colgate reported a healthy ~15% volume growth in the toothpaste category, better than Dabur’s 3%, while oral care growth was muted for HULcare growth was muted for HUL.
Dabur’s domestic volume growth rebounded to ~8% YoY and shampoos posted a strong volume growth at 35% YoY in Q3FY12 v/s 16% YoY in Q2FY12.
GSK’s Q4CY11 volumes grew 11% YoY led by 16% YoY volume growth in Horlicks.
ITC’s cigarette volume growth slowed down largely due to base effect.
Volume growth Y‐o‐Y Q3FY12 (%) vs. expectationsColgate toothpaste 15 0Colgate‐toothpaste 15.0 Colgate‐toothbrush ~13‐14Asian Paints 10.0 Emami* 10.0 Godrej Consumer ‐ Soap* 19.0 Hindustan Unilever 9.1 ITC ‐ cigs 5.0 Marico 20.0 United Breweries 5.0 Dabur (domestic) 8.0 USL 1.0 Tata Global Beverages ~3‐4GSK Consumer 11.0 Bajaj Corp 20.5
Coca‐Cola India 20.0 Unilever PLC (Parent) 0.1
8
Source: Company, Edelweiss research * Domestic nos.
Colgate‐Palmolive Co (Parent) 4.0
Trend 1: Volume spur on (Contd…)
Revenues (INR mn) Q3FY12 Q3FY11 growth (%)Hindustan Unilever 59,376 51,277 15.8 ITC 61,954 54,243 14.2 Asian Paints 25,605 20,996 22.0 Dabur 14,527 10,800 34.5 , ,Colgate 6,898 5,766 19.6 Godrej Consumer 13,441 9,888 35.9 Marico 10,578 8,177 29.4 Emami 4,573 4,060 12.6 USL 19,539 19,601 (0.3) Nestle 19,547 16,710 17.0 Agro Tech 1,816 1,956 (7.2) GSK Consumer 6,248 5,242 19.2 Britannia Industries 12,491 10,834 15.3 Godfrey Phill ips 4,821 4,247 13.5 VST Industries 1 701 1 387 22 7VST Industries 1,701 1,387 22.7 Zydus Wellness 755 909 (16.9) Berger Paints 7,823 6,201 26.2 Kansai Nerolac 6,655 5,601 18.8 Pidilite 7,680.5 6,593.2 16 Tata Global Beverages 18,018 16,060 12.2
HUL reported a robust 9.1% volume growth (high base of 13% in Q3FY11); double-digit sales growth across
Source: Company, Edelweiss research
Tata Global Beverages 18,018 16,060 12.2 Bajaj Corp 1,125 862 30.6
segments though most segments disappointed, except soaps and detergents.
USL’s 1% volume growth disappointed due to issues in Tamil Nadu (volume loss of 1.5mn cases) and West Bengal (volume drop of 48% YoY for industry).
Emami’s 10% volume growth on back of market share gains in a few categories.
9
Trend 2: Ad spend under control; some revival
Four out of 13 companies have cut ad spending on an absolute basis to reduce pressure on margins (v/s three out of 13 in Q2FY12).
Six have cut ad spending in terms of % of sales, indicating a revival in ad spending (v/s 10 out of 13 in Q2FY12).
In our view some companies like Dabur have upped the ante in ad spend in order to regain market share and In our view, some companies like Dabur have upped the ante in ad spend in order to regain market share and achieve higher volume growth.
A&P YoY Growth (%) Change in bps YoY
Dabur 46.9 114 Godrej Consumer* 1.4 (284) Marico 48.6 164 Emami 1.8 (187) USL 11.7 119 Agro Tech (47.2) (401) GSK Consumer 27 1 113GSK Consumer 27.1 113 Hindustan Unilever (7.1) (287) Colgate (10.9) (533) Zydus Wellness (4.3) 118 Tata Global Beverages 22.3 156 Britannia Industries 17.4 13
Marico saw an increase in ad spends primarily largely due to new brand launches.
Source: Company, Edelweiss research * Domestic nos.
Britannia Industries 17.4 13 Godfrey Phill ips (0.2) (208)
HUL’s reduction in ad spends helped the company expand its EBITDA margin.
GCPL’s A&P spends in Q3FY12 were almost stable on an absolute basis due to fewer launches.
GSK’s high A&P spends was due to heavy promotional spends for the launch of oats and relaunch of Boost which is primarily a one off The company expects A&P spends to be ~15 16% of salesprimarily a one‐off. The company expects A&P spends to be ~15‐16% of sales.
10
Trend 3: Strain on gross margin; worst likely behind
G i h d li d f 12 t f 21 i (di d f 15 i t f 21 i Q2FY12) d t Gross margins have declined for 12 out of 21 companies (dipped for 15 companies out of 21 in Q2FY12) due to severe raw material inflation.
Cigarette companies saw margin expansion due to high pricing power and benign raw materials.
Calibrated price hikes and superior product mix helped GCPL, Marico, Emami, Nestle and Britannia expand gross margin by 20bps, 114bps 203bps, 220bps and 300bps, respectively.
Agro Tech’s focus on improving margins helped the company improve gross margins by 589bps.
Most players are focused on growing volume rather than gross margin.
Gross margins Q3FY12 Q3FY11 Change in bps YoYHindustan Unilever 48.2 49.9 (169) ITC ‐ cigs* 31.7 29.3 240 Asian Paints 39.4 40.3 (90) Dabur 49 4 51 9 (248)Dabur 49.4 51.9 (248) Colgate 61.6 62.5 (90) Godrej Consumer 53.5 53.3 20 Marico 48.5 47.3 114 Emami 62.4 60.3 203 USL 39.1 41.0 (190) ( )Nestle 54.6 52.4 220 Agro Tech 30.0 24.2 589 GSK Consumer 65.7 66.0 (24) Britannia Industries 36.7 33.7 300 Godfrey Phill ips 63.7 61.5 219 VST Industries 54.8 53.5 138 Zydus Wellness 61.9 62.9 (97) Berger Paints 35.6 36.5 (89) Kansai Nerolac 33.0 33.7 (68) Pidil ite 42.9 45.9 (297) Tata Global Beverages 58 0 58 9 (99)
Source: Company, Edelweiss research
11
* Cigarette business EBIT margins
Tata Global Beverages 58.0 58.9 (99) Bajaj Corp 54.3 56.4 (210)
Trend 4: EBITDA margin dips, but a few manage better
EBITDA margin of 12 out of 21 companies declined (declined for 14 out of 21 companies in Q2FY12) However fall EBITDA margin of 12 out of 21 companies declined (declined for 14 out of 21 companies in Q2FY12). However, fall in EBITDA margin is much lower than fall in gross margin in most cases.
EBITDA margin of most companies declined primarily on account of raw material inflation.
However, a dip in EBITDA margin was cushioned by moderation in ad spending. , p g y p g
HUL, ITC, Colgate, GCPL, Emami, Nestle, Agro Tech, Britannia and VST have managed margins well.
Low margin segments did well. HUL’s S&D margins expanded for three consecutive quarters (7.5% in Q4FY11 to 9.2% in Q1FY12 to 12.4% in Q2FY12 to 13.5% in Q3FY12). Britannia’s margins too expanded by 130bps YoY.
EBITDA margins Q3FY12 Q3FY11 Change in bps YoYHindustan Unilever 16.3 14.1 221 ITC 37.6 36.3 130 Asian Paints 15.5 16.4 (90) Dabur 15.8 19.9 (407) Colgate 21.6 16.1 550 Godrej Consumer 19.7 16.8 290 Marico 11.5 12.2 (68) Emami 25.8 25.1 69 USL 9 6 14 1 (450)USL 9.6 14.1 (450) Nestle 21.1 19.7 140 Agro Tech 8.5 (1.3) 977 GSK Consumer 13.5 14.3 (78) Britannia Industries 6.7 5.4 130 Godfrey Phill ips 14.5 14.7 (21)Godfrey Phill ips 14.5 14.7 (21) VST Industries 32.6 29.8 281 Zydus Wellness 28.2 30.9 (272) Berger Paints 10.1 11.0 (91) Kansai Nerolac 12.1 12.3 (16) Pidil ite 14.9 17.3 (235)
Source: Company, Edelweiss research12
Tata Global Beverages 10.0 11.5 (142) Bajaj Corp 25.5 30.2 (473)
Trend 5: Pricing power continues
Quality of sales growth was better with balanced blend of price and volume growth.
Most companies have taken calibrated price hikes, but not completely to the extent of rise in commodity prices. Hence, EBITDA margins have contracted.
However, empirically, it has been observed that with deflation in raw material, companies seldom roll back prices completely, which could lead to margin expansion. Also, they roll back prices with a lag.
Price hike Product wise price hike
Company Price hike (%)Marico 9.3 Asian Paints 12.0 Colgate‐toothbrush ~3‐4
Category Price hike (%)MaricoConsumer Products Business (India) 22.0 Parachute Coconut Oil (Rigid packs) 27.0
Dabur (domestic) 8.0 Hindustan Unilever 6.7 ITC ‐ cig ~6USL 12.0 Tata Global Beverages ~3‐4Bajaj Corp 10 1
Coconut Oil 30.0 Value Added Hair Oils 20.0 Saffola 14.0
Dabur (domestic)Shampoos (31.0) Toothpaste 11 4
Source: Company, Edelweiss research
Bajaj Corp 10.1 GSK Consumer 8.0
Toothpaste 11.4 GCPLSoaps 12.0
GSK ConsumerBiscuits 14.0
Colgate
Source: Company, Edelweiss research
ColgateToothbrush ~3‐4
13
Trend 6: Pace of new launches picks up
Q3FY12 saw launches of several new products and categories by HUL, ITC, GCPL, Dabur, Marico and Colgate.
New products and innovations
Company New Product LaunchHUL Lux Handwash, AXE Shower gels, Dove body lotions range
Clinic Plus conditioners, Sunsilk KeratinologyBru Gold – 100% coffee Surf Excel Quickwash and Pepsodent G relaunched
Dabur Dabur Almond Hair OilNew variants of Hajmola launched
GCPL HIT extra power electric mosquito repellant in IndonesiaTouch of Silver Intensive Conditioner and Cuticura Vitamin E Night and Day cream in UK
Marico Two new variants of Saffola Arise: long grain and basmati
Parachute Advansed Body Lotion, Saffola Masala OatsColgate Colgate 360° Sonic Power and Colgate ZigZag Anti‐Germ toothbrushes
Colgate Barbie and Colgate Spiderman (toothbrush and toothpaste in kids segment)ITC Vivel Clear 3 in 1 soap
Di Wills range of hair care treatment in three variants
Fiama Di Wills Face and Body Talc in select marketsGSK C L h d H li k O t d l h d B t
Source: Company, Edelweiss research
GSK Consumer Launched Horlicks Oats and relaunched BoostBritannia NutriChoice Multigrain Thins, NutriChoice Multigrain Rosty, 50‐50 Snackuits
14
Trend 7: International sales growth robust for most players
Companies reported robust growth in international business despite global economic pressure.
Marico’s international business was~23% of the Group’s turnover in FY11 and grew 16% YoY (organic) in Q3FY12.
Dabur’s organic growth in international business was a robust 37.8% despite political disturbances in Middle East.
GCPL’s international margins expanded on back of strong performance in Indonesia and Africa.
Emami’s international business declined primarily due to slowdown in Africa; however, growth in other regions remained intact (Middle East: 50% YoY and GCC: 40% YoY growth).
Companies are also planning introduction of a few international products in India.
International business
Company Growth (%)Asian Paints FlatDabur* 37.8
Company International sales as % of total revenueHUL 1.0 Emami 14.0
Source: Company, Edelweiss research * Organic growth
Godrej Consumer* 30.0 Marico* 16.0 Emami (7.0)
Dabur 20.0 GCPL 33.0 Marico 24.0
Note: FY11 data
15
Annexure
Rural focus bolsters volume
Rural India remains a major focus area for all companies.
Rural consumption market stood at ~USD190bn in 2010 and is expected to triple to USD600bn in next 10 years.
Companies are increasingly focusing on rural expansion with specific products and direct distributionCompanies are increasingly focusing on rural expansion with specific products and direct distribution.
Most companies have rural growth outstripping urban growth.
Emami’s rural sales contribution has been consistently increasing and is 50% of total sales as of Q3FY12.
Dabur does not see a slowdown in rural areas which contributes a little more than 50% to sales. The company has a massive extension plan to increase its direct reach in rural India.
For Marico, rural growth outpaced urban (rural sales contribute 40% to total Parachute sales).
% of sales Rural Urban
Source: Company, Edelweiss research
Dabur 50.0 50.0 Emami 50.0 50.0 Bajaj Corp 36.0 64.0
17
Key raw material: Price trend
Palm OilPalm Oil
4,000
4,800
1,600
2,400
3,200
(INR)
800
,
Feb‐02
Feb‐03
Feb‐04
Feb‐05
Feb‐06
Feb‐07
Feb‐08
Feb‐09
Feb‐10
Feb‐11
Feb‐12
Copra7,500
4,500
5,500
6,500
(INR/Qtl)
2,500
3,500
‐06
‐07
‐08
‐09
‐10
‐11
‐12
18Source: Company, Edelweiss research
Feb‐
Feb‐
Feb‐
Feb‐
Feb‐
Feb‐
Feb‐
Key raw material: Price trend and Edelweiss commodity index
LLP PackagingLLP Packaging
54
62
70
INR/lt)
LLP price have increased further
84
90
g)
HDPE prices have not increased
38
46
54
(Liquid Paraffin
66
72
78
(HDPE
INR/kg
30
Feb‐10
Apr‐10
Jun‐10
Aug
‐10
Oct‐10
Dec
‐10
Feb‐11
Apr‐11
Jun‐11
Aug
‐11
Oct‐11
Dec
‐11
60
Feb‐10
Apr‐10
Jun‐10
Aug
‐10
Oct‐10
Dec
‐10
Feb‐11
Apr‐11
Jun‐11
Aug
‐11
Oct‐11
Dec
‐11
Commodity Index
40.0
60.0
139
155
(20 0)
0.0
20.0
91
107
123
RM pressure softeneing
(40.0)
(20.0)
75
91
Jan‐07
Apr‐07
Jul‐0
7
Oct‐07
Jan‐08
Apr‐08
Jul‐0
8
Oct‐08
Jan‐09
Apr‐09
Jul‐0
9
Oct‐09
Jan‐10
Apr‐10
Jul‐1
0
Oct‐10
Jan‐11
Apr‐11
Jul‐1
1
Oct‐11
Jan‐12
softeneing
19
Source: Company, Edelweiss research
Y‐o‐Y Inflation (RHS) Edelweiss RMP weighted price Index
Disclaimer
This document has been prepared by Edelweiss Securities Limited (Edelweiss). Edelweiss, its holding company and associate companies are a full service, integrated investment banking, portfolio management and brokerage group. Ourresearch analysts and sales persons provide important input into our investment banking activities. This document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation ofany transaction. The information contained herein is from publicly available data or other sources believed to be reliable, but we do not represent that it is accurate or complete and it should not be relied on as such. Edelweiss or any of itsaffiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This document is provided for assistance only and isnot intended to be and must not alone be taken as the basis for an investment decision The user assumes the entire risk of any use made of this information Each recipient of this document should make such investigation as it deemsnot intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigation as it deemsnecessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risksof such investment. The investment discussed or views expressed may not be suitable for all investors. We and our affiliates, group companies, officers, directors, and employees may: (a) from time to time, have long or short positions in,and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as advisor or lender/borrower to such company(ies) or have other potential conflict of interest with respect to any recommendation and related information and opinions. This information is strictly confidential and is being furnished to you solely for your information. This informationshould not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, anyperson or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Edelweiss andaffiliates/ group companies to any registration or licensing requirements within such jurisdiction. The distribution of this document in certain jurisdictions may be restricted by law, and persons in whose possession this document comes,should inform themselves about and observe, any such restrictions. The information given in this document is as of the date of this report and there can be no assurance that future results or events will be consistent with this information.This information is subject to change without any prior notice. Edelweiss reserves the right to make modifications and alterations to this statement as may be required from time to time. However, Edelweiss is under no obligation to updateThis information is subject to change without any prior notice. Edelweiss reserves the right to make modifications and alterations to this statement as may be required from time to time. However, Edelweiss is under no obligation to updateor keep the information current. Nevertheless, Edelweiss is committed to providing independent and transparent recommendation to its client and would be happy to provide any information in response to specific client queries. NeitherEdelweiss nor any of its affiliates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including lost revenue or lost profits that may arise fromor in connection with the use of the information. Past performance is not necessarily a guide to future performance. The disclosures of interest statements incorporated in this document are provided solely to enhance the transparency andshould not be treated as endorsement of the views expressed in the report. Edelweiss Securities Limited generally prohibits its analysts, persons reporting to analysts and their family members from maintaining a financial interest in thesecurities or derivatives of any companies that the analysts cover. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and itsor their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Copyright 2007 Edelweiss Research (Edelweiss Securities Ltd). All rightsreserved.
For recipients in the United States: This presentation was prepared by Edelweiss Securities which is not a FINRA member nor a broker dealer registered with the SEC US persons receiving this research and wishing to effect any
20
For recipients in the United States: This presentation was prepared by Edelweiss Securities, which is not a FINRA member nor a broker-dealer registered with the SEC. US persons receiving this research and wishing to effect anytransactions in any security discussed in the report should contact an SEC-registered broker-dealer. In order to conduct business with Institutional Investors based in the U.S., Edelweiss Securities has entered into a chaperoning agreementwith a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo").
Copyright 2009 Edelweiss Research (Edelweiss Securities Ltd). All rights reserved